Corcept Therapeutics
CORT
#1642
Rank
A$18.63 B
Marketcap
A$172.37
Share price
1.42%
Change (1 day)
27.89%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of June 2026 : A$13.5 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is A$13.5 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$9.11 M-18.24%
2024-12-31A$11.15 M4931.3%
2023-12-31A$0.22 M-86.8%
2022-12-31A$1.67 M131.5%
2021-12-31A$0.72 M-78.13%
2020-12-31A$3.31 M-32.89%
2019-12-31A$4.94 M
2018-12-31N/A
2016-12-31A$20.34 M-0.97%
2015-12-31A$20.54 M78.39%
2014-12-31A$11.51 M78.85%
2013-12-31A$6.43 M152.49%
2012-12-31A$2.55 M
2010-12-31N/A-100%
2009-12-31A$0 M-70.55%
2008-12-31A$0.02 M-31.63%
2007-12-31A$0.03 M-37.74%
2006-12-31A$0.05 M-27.81%
2005-12-31A$0.07 M
2003-12-31A$0.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$70.30 B 520,396.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$70.27 B 520,163.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$90.60 B 670,678.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$78.72 B 582,725.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$77.28 B 572,089.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$64.59 B 478,118.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.47 B 3,411.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.36 B 2,581.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$6.02 B 44,504.61%๐Ÿ‡บ๐Ÿ‡ธ USA